Jeil Pharma Holdings (XKRX:002620) Net Change in Cash : ₩159 Mil (TTM As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Jeil Pharma Holdings's Net Change in Cash for the three months ended in Mar. 2024 was ₩-3,583 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ₩159 Mil.

Jeil Pharma Holdings Net Change in Cash Historical Data

The historical data trend for Jeil Pharma Holdings's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Net Change in Cash Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-19,861.16

-1,053.56

8,397.39

6,178.73

2,279.12

Jeil Pharma Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-1,462.17	9,747.45	-8,508.21	2,502.06	-3,582.55

Jeil Pharma Holdings Net Change in Cash Calculation

Jeil Pharma Holdings's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-4415.63	+	-13425.021	+	20616.065	+	-496.292
	=	2,279

Jeil Pharma Holdings's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 1285.033 + -1775.318 + -3660.461 + 568.195

= -3,583

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩159 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeil Pharma Holdings Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Jeil Pharma Holdings's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Net Change in Cash

Comparable Companies

XKRX:176750 XKRX:214390 XKRX:023910 XKRX:082800 XKRX:061250 XKRX:002390 XKRX:006620 XKRX:003120 XKRX:002210 XKRX:389470 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines